Peptide ProvidersDirect

Trust center

Editorial policy

Editorial work prioritizes traceable evidence, restrained medical language, conflicts disclosure, and human accountability.

Standards

Editors distinguish a provider’s claim from an independently checked fact and avoid unqualified efficacy, safety, equivalence, or legality statements.

  • Medical and regulatory content requires qualified review.
  • AI-generated drafts remain unpublished until reviewed.
  • Material corrections retain an audit history.

Conflicts

Reviewers must disclose material personal or commercial relationships. Sponsorship teams cannot assign verification status or suppress corrections.

Last operational review: July 15, 2026. Contact information will be added before public launch.